DIN 02301407 — ACT CABERGOLINE 0.5 MG
ACT CABERGOLINE is a tablet of Cabergoline marketed by TEVA CANADA LIMITED. The full Cabergoline monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02301407
- Brand name
- ACT CABERGOLINE
- Active ingredient
- Cabergoline
- Strength
- 0.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- DORMANT
- Drug class
- Dopamine receptor agonist (ergot derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cabergoline products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02455897 | APO-CABERGOLINE | 0.5 MG | TABLET | APOTEX INC | MARKETED |
| 02242471 | DOSTINEX | 0.5 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02549611 | JAMP CABERGOLINE | 0.5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |